Rifaximin is a semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. It also acts as a pregnane X receptor (PXR) agonist. It is approved for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It is used to prevent and treat milk cow mastitis in the dry period caused by sensitive bacteria such as Staphylococcus aureus, Streptococcus and E. coli.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Infection | Antibacterial
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。